No “Constraining Situation” On gVascepa API Says Strides MD, Q3 Revenues Jump
gSuprep Likely To Be Launched In Q4
Strides intends to keep US momentum going with Amneal-partnered generic Vascepa, where Hikma and Dr. Reddy’s have filed antitrust suits against Amarin over API supply. Meanwhile, the founder re-iterated ambitious goals set for Stelis and its CDMO business
